Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-21 Sale |
2021-09-22 6:08 pm |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
6,650 | $150.05 | $997,833 | 18,923 (Direct) |
View |
| 2021-09-08 Sale |
2021-09-09 5:07 pm |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
1,413 | $130 | $183,690 | 18,923 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-06 7:12 pm |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
2,056 | $122.56 | $251,988 | 16,163 (Direct) |
View |
| 2020-09-08 Sale |
2020-09-09 5:49 pm |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
2,000 | $89.5 | $179,004 | 19,161 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-03 Option Award |
2025-02-04 4:23 pm |
N/A 2035-02-02 |
Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 8:05 pm |
N/A 2034-05-22 |
Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. |
75,000 | $0 | 75,000 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-26 4:46 pm |
N/A 2034-01-23 |
Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. |
110,000 | $0 | 110,000 (Direct) |
View |
Ownership |
2023-09-13 8:48 pm |
N/A 2033-06-28 |
Dianthus Therapeutics Inc. | DNTH | Veness Adam M See Remarks |
0 | $0 | 88,240 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:14 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | Veness Adam M General Counsel |
96,100 | $0 | 96,100 (Direct) |
View |
| 2022-05-02 Option Award |
2022-05-04 4:22 pm |
N/A 2032-04-25 |
Cyteir Therapeutics Inc. | CYT | Veness Adam M General Counsel |
177,000 | $0 | 177,000 (Direct) |
View |
| 2021-11-19 Equity Swap |
2021-11-22 09:05 am |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
23,423 | $0 | 0 (Direct) |
View |
| 2021-11-09 Exercise |
2021-11-12 4:15 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
4,500 | $29.37 | 23,423 (Direct) |
View |
| 2021-11-09 Exercise |
2021-11-12 4:15 pm |
N/A 2024-08-01 |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
4,500 | $0 | 23,423 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 6:08 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
1,450 | $41.2 | 18,923 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 6:08 pm |
N/A 2027-03-02 |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
6,650 | $0 | 18,923 (Direct) |
View |
| 2021-09-21 Exercise |
2021-09-22 6:08 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
5,200 | $30.17 | 18,923 (Direct) |
View |
| 2021-09-07 Tax Withholding |
2021-09-09 5:07 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
587 | $129.36 | 18,923 (Direct) |
View |
| 2021-06-07 Tax Withholding |
2021-06-08 6:53 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
108 | $126.69 | 20,923 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 7:50 pm |
N/A 2031-01-29 |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
23,674 | $0 | 39,837 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-06 7:12 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | Veness Adam M SVP, General Counsel and Sec. |
942 | $124.31 | 16,163 (Direct) |
View |